乙细胞和动脉样硬化之间的相互作用.
Luc Rochette1, Geoffrey Dogon1, Eve Rigal1
1Équipe d'accueil (EA 7460) : physiopathologie et épidémiologie cérébro-cardiovasculaires (PEC2), faculté des sciences de santé, université de Bourgogne-Franche-Comté, 7, boulevard Jeanne-d'Arc, 21000 Dijon, France.
Archives of cardiovascular diseases
|September 2, 2023
概括
有效的细胞分裂,即细胞清除死细胞,对于组织稳态和预防炎症至关重要. 功能受损的细胞增生有助于慢性炎症疾病,突出其治疗潜力.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 细胞死亡和转换是成年人的日常过程.
- 消化细胞的清除,即细胞对亡细胞的清除,对于组织平衡和预防炎症至关重要.
- 功能失调的乙细胞增生有助于慢性炎症性疾病.
研究的目的:
- 阐明细胞在维持组织平衡和调节炎症过程中的作用.
- 探索线粒体动力学,氧化应激和细胞分裂之间的联系.
- 突出自的重要性,以支持细胞增生及其在炎症疾病中的含义.
主要方法:
- 审查现有的文学关于efferocytosis,自和炎症过程.
- 在线粒体裂变,反应性氧物种和氧化应激过程中的分子机制的分析.
- 检查了在各种慢性炎症病症中细胞体的作用.
主要成果:
- 有效的乙细胞酶可以防止二次性亡和随后的炎症.
- 自对于细胞增生至关重要,特别是在中性粒细胞和巨细胞中,并支持关键的中性粒细胞功能.
- 失败的血细胞增生与动脉样硬化,神经退行性疾病,癌症和心脏病理有关.
- 在巨细胞中受损的血细胞增生与动脉样硬化严重程度和斑块脆弱性相关.
结论:
- 细胞分裂是解决炎症和保护组织的关键内源过程.
- 增强乙细胞酶的治疗策略可以有效地治疗和预防慢性炎症和代谢疾病.
- 向乙细胞分裂为管理心血管和代谢疾病提供了一个有希望的途径.
相关概念视频
Inflammation
53.8K
Overview
53.8K
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Receptor-mediated Endocytosis
104.7K
Overview
104.7K


